Summer 2026

Intern – Product Manager

Thoracolumbar-Fixation

Posted on 2/21/2026

Orthofix

Orthofix

1,001-5,000 employees

Develops spine and orthopedic reconstructive devices

Compensation Overview

$22 - $26/hr

Carlsbad, CA, USA

In Person

Category
Product (1)

Get referred to Orthofix

See people who can refer or advise you

Requirements
  • Pursuing a Bachelor's degree in Biomedical Engineering, Mechanical Engineering, Business, Marketing, or a related field.
  • Strong analytical and problem-solving skills.
  • Excellent verbal and written communication skills.
  • Ability to work independently and manage multiple tasks in a fast-paced environment.
  • Proficiency in Microsoft Office (Excel, PowerPoint, Word).
Responsibilities
  • Market & Competitive Analysis: Research market trends, competitor product offerings, and clinical applications within thoracolumbar spinal fixation.
  • Create reports and presentations to summarize key findings.
  • Product Development & Support: Assist in the evaluation of new and existing implants and instruments for thoracolumbar fixation.
  • Participate in cadaveric labs and surgeon feedback sessions to gather insights.
  • Support the product manager in data collection, testing, and documentation.
  • Sales & Business Support: Analyze sales performance, pricing trends, and customer feedback for TL fixation products.
  • Assist with sales training materials, product guides, and marketing collateral.
  • Help prepare internal and external presentations for product updates.
  • Operational & Cross-Functional Collaboration: Work with R&D, marketing, regulatory, and supply chain teams to track product milestones.
  • Support planning for product launches, line extensions, and instrument enhancements.
  • Contribute to the creation of FAQs, case studies, and training modules for field sales teams.
Desired Qualifications
  • Power BI experience is a plus.
  • Interest in medical devices, orthopedics, or spine surgery is highly preferred.

Orthofix Medical Inc. focuses on reconstructive and regenerative orthopedic and spine solutions for surgeons and hospitals. It operates in two groups: Global Spine, which offers spinal fusion products such as bone growth stimulators, spinal implants, and biologics, and Global Orthopedics, which provides devices for fracture fixation, deformity correction, and bone reconstruction. The company’s products are used to treat musculoskeletal conditions like degenerative disc disease, spinal stenosis, and fractures, and are sold through a direct sales force and a network of independent distributors in the U.S. and internationally. Orthofix grows by developing and commercializing new products and by acquiring complementary technologies and businesses, expanding its portfolio and market reach. Its goal is to improve musculoskeletal health by delivering a broad range of surgical solutions for spine and orthopedic care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Lewisville, Texas

Founded

1980

Get referred to Orthofix

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • International distribution in more than 60 countries can accelerate new product launches.
  • Biologics, implants, and bone growth therapies support cross-sell across one surgical workflow.
  • Specialized reconstruction products expand exposure to complex trauma and deformity procedures.

What critics are saying

  • M6-C and M6-L discontinuation shows persistent weakness in motion-preservation revenue.
  • Distributor and rep turnover can quickly reduce surgeon coverage and case conversion.
  • Quality issues or product recalls could damage multiple spine and orthopedics franchises simultaneously.

What makes Orthofix unique

  • Focused spine and limb reconstruction portfolio with enabling technologies like 7D FLASH.
  • Hybrid direct sales and distributor model supports broad global commercialization.
  • Two segments, Global Spine and Global Orthopedics, create multiple procedure attach points.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

16%

1 year growth

16%

2 year growth

16%
Yahoo Finance
Apr 9th, 2026
Orthofix restructures spine leadership, reports $196.7M Q1 sales and reaffirms 2026 outlook

Orthofix Medical has restructured its Spine leadership team to accelerate growth and execution, with key leaders now reporting directly to CEO Massimo Calafiore. The company eliminated the President, Global Spine Solutions role, whilst Shaeffer Bannigan assumes expanded responsibilities for Spine strategy and commercial operations. The medical technology company reported preliminary first quarter 2026 net sales of approximately $196.7 million, representing a 0.4% increase on a reported basis and 3% growth on a non-GAAP pro forma constant currency basis compared to Q1 2025. Non-GAAP pro forma net sales, excluding M6 disc sales, totalled approximately $196.4 million. The reorganisation aims to streamline decision-making and strengthen focus on the 7D navigation platform commercialisation. Patrick Fisher has also expanded his remit to include Biologics alongside Limb Reconstruction.

Precedence Research
May 30th, 2025
Xtant Medical Launches OsteoFactor Pro A Groundbreaking Growth Factor Solution to Advance Bone Healing

Xtant Medical launches OsteoFactor Pro A groundbreaking growth factor solution to advance bone healing.

Stock Titan
Mar 12th, 2025
Orthofix Announces Appointment of Vickie Capps to Board of Directors

Orthofix announces Appointment of Vickie Capps to Board of Directors.

PR Newswire
Feb 27th, 2025
The World Brain Mapping Foundation Rises From The Ashes Of The Pacific Palisades Fires To Host The Prestigious Gala And Convention In Los Angeles On The Eve Of The Oscars

LOS ANGELES, Feb. 26, 2025 /PRNewswire/ -- The World Brain Mapping Foundation (WBMF) is set to make a powerful comeback. On March 1st, it will host its 22nd Annual Gathering for the Cure (GFC) award gala at the Millennium Biltmore Hotel in Los Angeles. The red carpet will take place from 6:00 to 8:00 p.m., followed by the award banquet from 8:00 to 11:00 p.m

BioSpace
Feb 18th, 2025
Orthofix To Participate In The Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 9:00 am Pacific TimeLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT.Interested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix investor relations website at ir.orthofix.com.Internet Posting of InformationOrthofix routinely posts information that may be important to investors in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.About OrthofixOrthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system

INACTIVE